Skip to content

Accelerated Continue Theta-burst Stimulation (acTBS)Treatment for Obsessive Compulsive Disease

Accelerated cTBS and 1HZ-rTMS in the Treatment of Obsessive-compulsive Disorder With Individualized Stimulation Target

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05221632
Enrollment
60
Registered
2022-02-03
Start date
2021-03-01
Completion date
2023-07-01
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accelerated Continue Theta-burst Stimulation, Functional Magnetic Resonance Imaging, Obsessive-Compulsive Disorder, Transcranial Magnetic Stimulation

Brief summary

The therapeutic effects of high-dose accelerated continue theta-burst stimulation (acTBS) and 1-Hz repetitive transcranial magnetic stimulation (rTMS) on obsessive-compulsive disorder (OCD) and its neural mechanism were investigated by functional MRI.

Detailed description

All patients underwent a medical evaluation that included physical examination and routine laboratory studies before and after transcranial magnetic stimulation (rTMS) treatment. Patients were randomly allocated to 1-Hz rTMS group,acTBS group and sham group. Patients ware allocated by random number. The decision to enroll a patient was always made prior to randomization. The 1-Hz rTMS group received one round of stimulation every day for 30 minutes with a total stimulation of 1800 pulses for 5 consecutive days. Patients in the acTBS group received 10 two-minute rounds of stimulation each day, spaced 50 minutes apart, with a total of 18,000 pulses for five days. Before the TMS treatment, Y-BOCS, Obsessions Symptom Scale revised (OCI-R), Hamilton Depression Scale (HAMD-17) and Hamilton Anxiety Scale (HAMA-14) were obtained by a trained investigator to assess baseline severity and other symptoms. The patients had receiving a battery measure of neuropsychological tests (standardized tests to investigate their cognitive problems, anxiety and depressive symptoms in daily life), magnetic resonance imaging scan in multimodalities。 After the last treatment, Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), OCI-R, HAMD-17 and HAMA-14 were obtained, as well as the Global Index of Safety to assess adverse events of the treatment. Patients were instructed to focus their answers on the past 5 days.The patients had also receiving a battery measure of neuropsychological tests and magnetic resonance imaging scan in multimodalities. Participants were interviewed for two and four weeks after their last treatment to obtain a Y-BOCS score, and they were asked to focus their answers on the past week.

Interventions

DEVICEAccelerated transcranial magnetic stimulation with real coil

The stimulation mode of TMS is accelerated continue theta-burst stimulation.

The stimulation mode of TMS is 1-Hz repetitive Transcranial magnetic stimulation .

The stimulation mode of TMS is accelerated continue theta-burst stimulation, but without active stimulation.

Sponsors

Anhui Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of obsessive-compulsive disorder * Voluntarily participated and cooperated with the experiment.

Exclusion criteria

* History of significant head trauma or neurological disorders. * Alcohol or drug abuse. * Organic brain defects on T1 or T2 images. * History of seizures or unexplained loss of consciousness. * Family history of medication refractory epilepsy. * Recent aggression or other forms of behavioral dyscontrol.

Design outcomes

Primary

MeasureTime frameDescription
Symptom improvement assessed by the Yale-Brown Obsessive Compulsive Scalepre-treatment; 1 day post-treatment; Change from baseline score at 1 monthThe Yale-Brown Obsessive Compulsive Scale is a test to rate the severity of obsessive-compulsive disorder symptoms, which measures obsessions separately from compulsions. The scale includes 10 items, the first 5 items are evaluated obsessions, the rest are assessments compulsions. Each item 0-4 points, a total of 40 points. The lower the score, the better the outcome.

Secondary

MeasureTime frameDescription
Obsessive Compulsive Inventory-Revised (OCI-R)pre-treatment; 1 day post-treatmenta simplified version of the OCI for self-assessment of Obsessive symptoms, Revised to include only 18 items from 42 items in the original Obsessive Compulsive Questionnaire. Divided into six obsessional subscales, respectively washing (5, 11, 17), obsessional thinking (6, 12, 18), storage (1, 7, 13), sorting (3, 9, 15), check (2, 8, 14), mixed (4, 10, 16), can be very good to distinguish the characteristics of different obsessional symptoms. Each item was assessed on a five-point scale of 0 to 4, with 0 being not at all and 5 being extremely painful, and participants were asked to tick a number that best described the extent of their pain or distress on a scale of 0 to 72, with higher scores indicating more severe obsessive-compulsive symptoms. The questionnaire is simple and easy to understand. It can objectively evaluate individual obsessive-compulsive symptoms from six dimensions, with high reliability (0.82) and validity (0.81).
Hamilton Depression Scale(HAMD)pre-treatment; 1 day post-treatmentHamilton Depression Scale(HAMD): An assessment of depressive mood status with 17 questions on a Scale of 0 to 4.
Hamilton Anxiety Scale(HAMA)pre-treatment; 1 day post-treatmentHamilton Anxiety Scale(HAMA):a scale of 14 questions on a scale of 0 to 4 on a 5 scale.
Stroop word testpre-treatment; 1 day post-treatmentTo measure the conflict suppression ability of the subjects, consisting of three groups of cards, namely dot, word and color word. The subjects were asked to read the color as quickly and accurately as possible, and record the response time and accuracy. Behavioral indicators :(Stroop interference effects, SIE)= reaction time of color word - reaction time of word.
Behavioral index TMT=TMT-B reaction time - TMT-A reaction time.pre-treatment; 1 day post-treatmentEvaluate the executive function of the subjects, including attention, memory, thinking flexibility, reasoning, conversion and other broad executive function components, including A and B. TMT is simple and involves less cognitive involvement. TMT-B involves response inhibition and attentional switching. The task required the subjects to complete the connection according to certain rules and record the reaction time. Behavioral index TMT=TMT-B reaction time - TMT-A reaction time.

Countries

China

Contacts

Primary ContactChunyan Zhu, professor
ayswallow@126.com+86-0551-62923704

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026